$228.97

+2.87 (+1.27%)

Weekly Expected Move ±7.5%

$182 $198 $214 $230 $246

NASDAQ · Healthcare · Medical - Devices · Alpha Radar Buy · Power 70 · $1.8B mcap · 7M float · 2.97% daily turnover · Short 76% of daily vol

Revenue

$603M +19.5% ▲

5Y CAGR: +27.4%

Gross Profit

$170M +16.2% ▲

5Y CAGR: +30.7%

Operating Income

$92M +14.1% ▲

5Y CAGR: +40.7%

Net Income

$68M +15.8% ▲

5Y CAGR: +38.6%

EPS (Diluted)

$8.77 +15.7% ▲

5Y CAGR: +37.7%

EBITDA

$116M +20.8% ▲

5Y CAGR: +36.3%

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$206M	$354M	$400M	$504M	$603M
YoY Growth	+15.0%	+71.5%	+13.1%	+26.1%	+19.5%
Cost of Revenue	$155M	$264M	$288M	$358M	$432M
Gross Profit	$51M	$90M	$112M	$147M	$170M
Gross Margin	24.8%	25.5%	28.1%	29.1%	28.3%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$29M	$46M	$51M	$62M	$77M
Operating Expenses	$30M	$35M	$55M	$66M	$78M
Operating Income	$21M	$55M	$58M	$81M	$92M
Operating Margin	10.3%	15.7%	14.4%	16.0%	15.3%
Interest Expense	$39K	$3M	$4M	$8M	$10M
Income Before Tax	$21M	$53M	$54M	$73M	$83M
Tax Expense	$5M	$11M	$9M	$14M	$14M
Net Income	$16M	$42M	$45M	$59M	$68M
Net Margin	7.7%	11.8%	11.2%	11.7%	11.3%
EPS (Diluted)	$2.09	$5.45	$5.83	$7.58	$8.77
EBITDA	$30M	$67M	$69M	$96M	$116M
Shares Outstanding	8M	8M	8M	8M	8M

Line Item	FY2024 Q2	FY2024 Q3	FY2024 Q4	FY2025 Q1	FY2025 Q2	FY2025 Q3	FY2025 Q4	FY2026 Q1
Revenue	$110M	$145M	$144M	$148M	$151M	$155M	$149M	$154M
Cost of Revenue	$77M	$104M	$102M	$106M	$108M	$112M	$107M	$110M
Gross Profit	$33M	$42M	$42M	$42M	$44M	$43M	$42M	$44M
Gross Margin	30.0%	28.6%	29.2%	28.5%	28.8%	27.7%	28.2%	28.8%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$14M	$16M	$19M	$19M	$19M	$19M	$21M	$21M
Operating Expenses	$15M	$17M	$20M	$19M	$19M	$19M	$20M	$21M
Operating Income	$18M	$25M	$22M	$23M	$24M	$23M	$22M	$23M
Operating Margin	16.3%	17.1%	15.4%	15.6%	16.1%	15.1%	14.4%	15.1%
Interest Expense	$577K	$3M	$3M	$3M	$3M	$2M	$2M	$2M
Income Before Tax	$17M	$21M	$19M	$20M	$22M	$21M	$20M	$22M
Tax Expense	$4M	$5M	$3M	$3M	$4M	$5M	$2M	$4M
Net Income	$14M	$16M	$16M	$17M	$17M	$16M	$18M	$17M
Net Margin	12.3%	11.3%	11.4%	11.6%	11.4%	10.6%	11.8%	11.3%
EPS (Diluted)	$1.75	$2.11	$2.10	$2.21	$2.21	$2.11	$2.24	$2.24
EBITDA	$21M	$29M	$27M	$28M	$29M	$28M	$31M	$28M
Shares Outstanding	8M	8M	8M	8M	8M	8M	8M	8M

UFPT NASDAQ